FGFR2-RUNX2 activation: An unexplored therapeutic pathway in luminal breast cancer related to tumor progression. - Rodriguez MS; Mahmoud YD; Vanzulli S; Giulianelli S; Spengler E; Martínez Vazquez P; Burruchaga J; Bushweller J; Lamb CA; Lüthy IA; Lanari C; Pérez Piñero C (International journal of cancer, 2025)